Delivering joined-up care for people with type 2 diabetes: rationale, challenges and examples

Approximately 3.8 million people in the UK have type 2 diabetes mellitus (T2DM) and are, as a consequence, at risk of developing micro- macrovascular disease. The rapid increase T2DM prevalence places considerable burden on secondary healthcare. New classes glucose-lowering medications (sodium-glucose co-transporter inhibitors glucagon-like peptide 1 receptor agonists) can improve outcomes for with T2DM; however, these options brought another layer complexity to managing this In combination, factors are calling into question suitability primary–secondary care healthcare model prompting professionals investigate alternative solutions. Bringing high-quality meeting their complex needs requires integrated multidisciplinary expertise community. However, setting up such systems within National Health Service (NHS) be challenging. complexities internal market (in NHS England), lack training expertise, inadequate information technology resistance change systemic individual level all constitute significant barriers establishing easy-to-access care. When removed, successful established, which alleviate pressure centres.